Ahead of the Bell: Exelixis shares tumble

September 2, 2014 1:14 PM

1 0

Shares of Exelixis Inc. shed more than half their value Tuesday before markets opened and a day after the drug developer said its potential treatment for an advanced form of prostate cancer fell short when compared with another drug in late-stage research.

The South San Francisco, California, company also said it will cut its workforce by about 70 percent, or 160 employees, because of the study results.

Read more

To category page